Early control architecture decisions can impact a facility’s long-term growth, flexibility, and efficiency.
John Hatzis
Advertisement
John Hatzis is a global Life Sciences industry consultant, at Rockwell Automation.
Articles by John Hatzis
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
ImvivaBio’s Dual-Target Allogeneic CAR-T Sustains Lupus Remission Through 12 Months
2
Amgen’s Dazodalibep Reduces Systemic Disease Activity in Phase 3 Sjögren’s Trial
3
Updates on Simtra BioPharma Solutions’ Bloomington Capacity Expansions
4
Beam's Risto-cel Meets Primary Endpoint in Sickle Cell Trial
5